How to choose the HPV vaccine in Chengdu Yishi Girl?Experts will take you back to the 2021 edition subsidy policy to focus on you!

Cover Journalist Zeng Ya

On September 26, the Chengdu Municipal Health and Health Commission and Chengdu Finance Department jointly issued a plan for matters related to the HPV vaccination in school -age girls in 2022. In November last year, Chengdu, as the first city in the west to promote the 13 -year -old female student in the school, generally vaccinated the HPV vaccine in the school, and the 2021 HPV vaccination subsidy policy attracted the attention of parents once it was released. Why is the HPV vaccine from 13 and 14 years old? How to choose the vaccine? Today, the reporter interviewed Wang Wei, chief physician of the Department of Vulva and Cervical Diseases of the Chengdu Women's and Children's Center Hospital, to review the subsidy policy in 2021 for your reference.

Domestic two prices (Xin Kening), imported binary, imported four -valent

Three vaccines for parents to choose from

Wang Wei said that a foreign study shows that the five years after the first life is a high risk period for HPV infection. After the initial life, 46%of women will be infected at least one HPV within 3 years. The risk of infection is the highest. The average time from the initial behavior to the first detection of HPV infection is only 2. June. The results of my country's HPV epidemiological research also showed that the HPV infection rate of the 15 -year -old age group has reached 30.55%.

Wang Wei emphasized that from the perspective of public sanitation, the second -valet, four -valent and nine -valent vaccine can prevent the 16 and 18 high -risk type HPV viruses well, and the second -valet and four -valent can prevent 70%of cervical cancer. Therefore, it is recommended to vaccinate and protect it as soon as possible. Do not blindly wait for high -priced vaccines. The vaccine that is vaccinated is a good vaccine.

The reporter noticed that in the "Implementation Plan for the Integrated HPV vaccination of cervical cancer in Chengdu (2021 Edition)", only three domestic two -valent (Xin Kening), imported two -valet, and imported four -valent vaccine for parents to choose from their own choice The subsidy standard is 600 yuan/person.

Why is it recommended to vaccinate HPV vaccines at the age of 13 to 14?

Wang Wei said that cervical cancer prevention is divided into three levels: first -level prevention is mainly HPV vaccine vaccination and health education. The second -level prevention is mainly cervical cancer screening. The third -level prevention is mainly the regular treatment of cervical cancer. Among them, in the first level of prevention, the World Health Organization prioritizes the 9 -year -old girl with HPV vaccine. According to the suggestion of my country's "Comprehensive Prevention and Control Guidelines for Cervical Cancer", the key target of HPV vaccine is 13 -15 The year old girl. According to the plan, Chengdu is a general inoculation of HPV vaccine at school girls 13 to 14 years old, and it is also a call for actively responding to the World Health Organization. From the perspective of foreign and domestic research, the HPV vaccine before sexual behavior is the highest in protecting women.

How should the vaccine choose?

During the interview, Wang Wei emphasized that the HPV vaccination was best to take over the first substantial contact of women. After infection, the prevention effect of the vaccine will be reduced. In order to wait for a high -priced vaccine, many people may be infected with the virus when they wait, and miss the best vaccine prevention opportunities.

At present, the HPV vaccine, which has been approved by China, has authorized institutions to prove its safety. Taking the first domestic HPV vaccine as an example, recently, "Liuye Knife-Infectious Disease" published the first analysis of the first domestic binary HPV vaccine (Xin Kening) phase III clinical trial. The results showed that during the 66 -month follow -up period, the HPV vaccine showed extremely high protection effects in the HPV 16/18 related lesions and continuous infections in the 18 -year -old female population of 18 to 45. The vaccine can effectively induce subjects to produce high and long -term HPV 16 and type 18 neutralizes and IgG antibodies, showing good immune persistence. In addition, the vaccine has extremely high safety. During the research period, no serious adverse incidents related to vaccination occurred during the study period, nor the abnormalities of adverse pregnancy ending related to vaccine vaccination and abnormal health status of newborns.

- END -